Clinical trial

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

NCT01106677

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Canagliflozin Normalized identity: canagliflozinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sitagliptin Normalized identity: sitagliptinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Metformin immediate release Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE3

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

PlaceboDRUG

CanagliflozinDRUG · verified · RxNorm: canagliflozin

SitagliptinDRUG · verified · RxNorm: sitagliptin

Metformin immediate releaseDRUG

Sponsors & collaborators

Janssen Research & Development, LLClead sponsor

Mapped research locations

St LouisMissouri, United States1 AtlantaGeorgia, United States1 San AntonioTexas, United States1 NashvilleTennessee, United States1 TampaFlorida, United States1 DenverColorado, United States1 Las VegasNevada, United States1 CharlotteNorth Carolina, United States1 Saint PetersburgRussia1 Little RockArkansas, United States1 IstanbulTurkey (Türkiye)1 Buenos AiresArgentina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01106677 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.